InvestorsHub Logo
Followers 24
Posts 5025
Boards Moderated 1
Alias Born 11/16/2007

Re: None

Thursday, 05/05/2011 2:17:39 PM

Thursday, May 05, 2011 2:17:39 PM

Post# of 2118
rickochey- response to you from other board



what is the overall sentiment of the financials? Positive? Negative?
Sorry, I haven't done any DD. i know I should't put you on the hot seat.



Most covering state to hold, although one analyst is saying buy. Myself, I don't think they're losing as much money and have enough cash to hold off a while and hopefully can come up with a partnership which removes most of the cost. Viaject seems to definately be beneficial to those with diabetes as listed below per the company.

•Safer therapy than currently marketed meal-time insulin treatments
•Closely mimics natural spike of first-phase insulin release in non-diabetics, possibly reducing the risk of hyperglycemia
•Lower dose of insulin required to adequately cover a meal compared to Humulin® and Humalog®, the market-leading insulin products
•Reduces the amount of insulin that remains in the bloodstream several hours after a meal, reducing the risk of hypoglycemia
•May prevent weight gain - big plus!!!